the samsung global research outreach (gro) program is samsung's (samsung electronics & affiliated samsung companies) academic research collaboration platform.

we annually invite world-class university researchers to submit innovative research proposals to foster collaborative relationships.

selected proposals will receive financial support for one year ranging from usd $70,000 to $100,000 including reasonable overhead. in some cases, larger awards may be possible for especially outstanding proposals. awards may be renewed up to three years, based on research outcomes and necessity for further research partnership driven by samsung. joint research proposals from multiple universities may also be accepted.

the gro program represents an opportunity for samsung and universities to build a mutually beneficial research relationship. we look forward to your participation.

the therapeutic idea award is designed to promote new ideas that are still in the early stages of development with the potential to yield highly impactful data and new avenues of investigation for novel therapeutics for amyotrophic lateral sclerosis (als) treatment. this mechanism supports conceptually innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancement in als therapeutics. proposed research projects should include a well-formulated, testable hypothesis based on strong scientific rationale that holds translational potential to improve als treatment and/or advances a novel treatment modality. projects that focus primarily on investigating the pathophysiology of als are outside the scientific scope of this mechanism.

the therapeutic development award supports the preclinical assessment of therapeutics for amyotrophic lateral sclerosis (als). the proposed studies are expected to be empirical in nature and product-driven but may have a hypothesis-driven approach, provided the focus is on therapeutics. it is anticipated that the agents and/or data generated from these awards will lead to the advancement of new therapies for als.

the w. garfield weston foundation is pleased to announce the launch of the 2014 targeted diseases program in frontotemporal dementia and progressive supranuclear palsy this april.

• goal: to provide targeted support for high impact, translational research in frontotemporal dementia and progressive supranuclear palsy.
• funding: $50,000 to $150,000 per year over 1 to 3 years to a maximum of $450,000 per project
• eligibility: the program is open to researchers at or above the level of postdoctoral fellow or equivalent from registered charitable institutions in canada.

the intent of the breakthrough award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. the critical components of this award mechanism are:

impact: research supported by the breakthrough award will have the potential for a major impact and accelerate progress toward ending breast cancer. the impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome.

research scope: research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development. two different funding levels, based on the scope of the research, are available under this program announcement/funding opportunity. funding levels 3 and 4 are available under a different program announcement (w81xwh-14-bcrp-breakthrough34). it is the responsibility of the principal investigator (pi) to select the funding level that is most appropriate for the research proposed.

the intent of the breakthrough award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. the critical components of this award mechanism are:

impact: research supported by the breakthrough award will have the potential for a major impact and accelerate progress toward ending breast cancer. the impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome.

research scope: research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development. two different funding levels, based on the scope of the research, are available under this program announcement. funding levels 1 and 2 are available under a different program announcement (w81xwh-14-bcrp-breakthrough12). it is the responsibility of the principal investigator (pi) to select the funding level that is most appropriate for the research proposed.

the innovator award supports visionary individuals who have demonstrated creativity, innovative work, and leadership in any field including, but not limited to, breast cancer. the innovator award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could ultimately lead to ending breast cancer.

the era of hope scholar award supports individuals who are early in their careers and have demonstrated significant potential for innovation in breast cancer research. these individuals should be exceptionally talented scientists who have shown that they are the “best and brightest” in their field(s) through extraordinary creativity, vision, and productivity. they should have demonstrated experience in forming effective partnerships and collaborations and should exhibit strong potential for leadership in the breast cancer research community.

the bmfrp idea development award is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the bmfrp vision of understanding and curing bone marrow failure (bmf) diseases. this award mechanism is designed to support new ideas. proposed research studies should have a high probability of revealing new avenues of investigation. research projects should include a well-formulated, testable hypothesis based on strong scientific rationale and a developed and well-articulated research approach. personnel on the proposed team should have a strong background in bmf research.

nserc, along with 11 other members of the international belmont forum— a group of the world’s major and emerging funders of global environmental change research and international science councils—jointly announced their participation in a collaborative action to advance arctic research.

this initiative encourages integrated teams of natural and social scientists, as well as stakeholders, to develop projects that leverage existing arctic observing systems, datasets and models to evaluate key sustainability challenges and opportunities in the arctic region.

by utilizing and developing (1) the relevant information streams and (2) the sustainability science necessary to assess, predict, inform, and communicate resilient pathways, this call for proposals seeks to advance research across four themes:

• the natural and living environment
• the built environment and infrastructures
• natural resource management and development
• governance

for its part, nserc will provide direct funding to eligible canadian researchers to participate in small collaboration and synthesis grants related to their activities in funded projects in the natural sciences and engineering, excluding actual research costs.